Nuvigil in trials for 'jet lag disorder'

It seemed like the offer of a lifetime — earn $2,500 by flying to France aboard a private luxury jet.

But as the fine print made clear, there would be no Eiffel Tower or chateaux, no foie gras or Bordeaux. Travelers were confined to a laboratory in either Toulouse or Rouffach with electrodes attached to their heads, testing whether a drug could keep their jet-lagged bodies awake.

That drug, Nuvigil from Cephalon, could become the first medicine specifically approved by the Food and Drug Administration to combat jet lag.